Artelo Biosciences Inc (ARTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Operating Expenses | 2,614 | 1,784 | 2,292 | 3,476 | 2,394 |
| Operating Income | -2,614 | -1,784 | -2,292 | -3,476 | -2,394 |
| Interest Expense | 0 | 0 | 0 | 0 | 5 |
| Other Income | 165 | 185 | 124 | 137 | 69 |
| Pre-tax Income | -2,449 | -1,599 | -2,168 | -3,339 | -2,330 |
| Net Income Continuous | -2,449 | -1,599 | -2,168 | -3,339 | -2,330 |
| Net Income | $-2,449 | $-1,599 | $-2,168 | $-3,339 | $-2,330 |
| EPS Basic Total Ops | -14.94 | -10.08 | -13.68 | -21.06 | -14.76 |
| EPS Basic Continuous Ops | -14.95 | -10.08 | -13.66 | -21.22 | -14.72 |
| EPS Diluted Total Ops | -14.94 | -10.08 | -13.68 | -21.06 | -14.76 |
| EPS Diluted Continuous Ops | -14.95 | -10.08 | -13.66 | -21.22 | -14.72 |
| EBITDA(a) | $-2,614 | $-1,784 | $-2,292 | $-3,476 | $-2,394 |